MANHARD KIMBERLY — SEC Form 4 filings
SEC reporting owner CIK 1202094. 8 Form 4 filings on record with FilingPulse; latest filed 2026-09-18.
Transaction summary — filings shown
Covers all 8 filings on record, filed 2024-05-30 to 2026-09-18. Counts and totals are arithmetic on values as filed — descriptive data, not a recommendation.
- Open-market purchases (code P, non-derivative): 1 leg across 1 filing — 10,000 shares, $139,800 total (shares × price as filed).
- Open-market sales (code S, non-derivative): 5 legs across 2 filings — 2,500 shares, $279,010 total (shares × price as filed).
- Other reported legs (grants, option exercises, tax withholding, gifts, derivative-security transactions, …): 9.
- Largest priced transaction: purchase of 10,000 shares @ $13.98 ($139,800) in Inhibrx Biosciences, Inc., filed 2024-08-30.
By issuer — same filings
Open-market purchase/sale legs on non-derivative securities, grouped by issuer. Role is as filed on the newest filing for that issuer. Dollar totals cover priced legs only (shares × price as filed). Ordered by priced transaction value, largest first.
| Issuer | Role (as filed) | Filings | Purchases (P) | Sales (S) | Other legs |
|---|---|---|---|---|---|
| Inhibrx Biosciences, Inc. (INBX) | Director | 7 | 1 leg · 10,000 sh · $139,800 | 5 legs · 2,500 sh · $279,010 | 4 |
| Inhibrx, Inc. (INBX) | Director | 1 | — | — | 5 |
Form 4 filings — MANHARD KIMBERLY
| Filed | Form | Issuer | Reported transactions | Source |
|---|---|---|---|---|
| 2026-09-18 | 4/A | Inhibrx Biosciences, Inc. (INBX) | Grant/award (A): 10,000 (derivative) @ $0 | EDGAR |
| 2026-09-15 | 4 | Inhibrx Biosciences, Inc. (INBX) | Sale (S): 500 @ $111.78 · Sale (S): 500 @ $110.26 · Sale (S): 500 @ $105.05 | EDGAR |
| 2026-09-10 | 4 | Inhibrx Biosciences, Inc. (INBX) | Sale (S): 500 @ $115.14 · Sale (S): 500 @ $115.80 | EDGAR |
| 2026-06-04 | 4 | Inhibrx Biosciences, Inc. (INBX) | Grant/award (A): 15,000 (derivative) @ $0 | EDGAR |
| 2025-05-29 | 4 | Inhibrx Biosciences, Inc. (INBX) | Grant/award (A): 15,000 (derivative) @ $0 | EDGAR |
| 2024-08-30 | 4 | Inhibrx Biosciences, Inc. (INBX) | Purchase (P): 10,000 @ $13.98 | EDGAR |
| 2024-05-30 | 4 | Inhibrx Biosciences, Inc. (INXB) | Grant/award (A): 30,000 (derivative) @ $0 | EDGAR |
| 2024-05-30 | 4 | Inhibrx, Inc. (INBX) | Disposition to issuer (D): 3,500 (derivative) · Disposition to issuer (D): 15,000 (derivative) · Disposition to issuer (D): 15,000 (derivative) · Disposition to issuer (D): 15,000 (derivative) · Disposition to issuer (D): 17,259 (derivative) | EDGAR |
FilingPulse's Form 4 archive currently extends back to 2024-01-11 and is expanding backward through EDGAR history — earlier filings by this insider may not be indexed yet. Names and roles are shown as filed.
Need this as JSON?
GET https://api.filingpulse.io/v1/insider-trades?owner_cik=1202094 returns every filing on this page — normalized, with footnotes and derivative legs — and webhooks push new filings to you in seconds. API docs →